Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 295.16 Mn | 170.76 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.90% |
| Dec 31, 2025 | 31.69% |
| Sep 30, 2025 | 31.81% |
| Jun 30, 2025 | -14.13% |
| Mar 31, 2025 | 75.58% |
| Dec 31, 2024 | -38.63% |
| Sep 30, 2024 | -1.42% |
| Jun 30, 2024 | -53.55% |
| Mar 31, 2024 | -41.97% |
| Dec 31, 2023 | -69.52% |
| Sep 30, 2023 | -138.16% |
| Jun 30, 2023 | -58.51% |
| Mar 31, 2023 | -51.87% |
| Dec 31, 2022 | -27.50% |
| Sep 30, 2022 | -19.59% |
| Jun 30, 2022 | -25.92% |
| Mar 31, 2022 | -56.28% |
| Dec 31, 2021 | -26.55% |
| Sep 30, 2021 | 106.05% |
| Jun 30, 2021 | 48.39% |